Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01019369 · ClinicalTrials.gov registry record · NA

Study of Self or Clinic Administration of DepoProvera

A NA study of Contraception, sponsored by Carolyn L. Westhoff.

Completed
Registry status
NA
Development phase
132
Enrollment target
1
Study location

NCT01019369 is a NA study of Contraception that has completed, run by Carolyn L. Westhoff. The registered enrollment target is 132 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01019369, a NA study of Contraception, has completed, sponsored by Carolyn L. Westhoff.

COMPLETED
Registry status
NA
Development phase
132 participants
Enrollment target
1
Study location

Study Summary

Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without the use of another effective method of contraception, thereby leaving them vulnerable to unintended pregnancy. This study will randomly assign women who present for contraceptive services to two groups: self or clinic administered SC DMPA. The participants will be followed for one year to compare continuation rates, acceptability, cost effectiveness, evidence of skin changes, and need for continued support between the two groups.

Conditions Studied

Interventions

  • DRUG Medroxyprogesterone 17-Acetate

Study Locations (1)

New York

  • Columbia University/New York Presbyterian Hospital - New York

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 2010-03
Est. Completion 2012-11
Phase NA

Sponsor

Carolyn L. Westhoff

1 total trials

What the Registry Record Tells You About NCT01019369

The ClinicalTrials.gov registry entry for NCT01019369 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (71% lower). The listed sponsor is Carolyn L. Westhoff, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Medroxyprogesterone 17-Acetate is the first listed.

NCT01019369 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01019369 about?

NCT01019369 is a clinical study titled "Study of Self or Clinic Administration of DepoProvera". Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without the use of another effective method of contraception, thereby leaving them vulnerable to unintended pregnancy. T...

What is the current status of trial NCT01019369?

This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2010-03. Estimated completion is 2012-11.

What conditions does trial NCT01019369 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT01019369?

The interventions under investigation include: Medroxyprogesterone 17-Acetate (DRUG).

Who is sponsoring clinical trial NCT01019369?

This trial is sponsored by Carolyn L. Westhoff, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01019369 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.